Natural History of Perinatal and Infantile Hypophosphatasia: A Retrospective Study.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
06 2019
Historique:
received: 30 08 2018
revised: 16 01 2019
accepted: 29 01 2019
pubmed: 14 4 2019
medline: 16 4 2020
entrez: 14 4 2019
Statut: ppublish

Résumé

To report clinical characteristics and medical history data obtained retrospectively for a large cohort of pediatric patients with perinatal and infantile hypophosphatasia. Medical records from academic medical centers known to diagnose and/or treat hypophosphatasia were reviewed. Patients born between 1970 and 2011 with hypophosphatasia and any of the following signs/symptoms at age <6 months were eligible: vitamin B6-dependent seizures, respiratory compromise, or rachitic chest deformity (NCT01419028). Patient demographics and characteristics, respiratory support requirements, invasive ventilator-free survival, and further complications of hypophosphatasia were followed for up to the first 5 years of life. Forty-eight patients represented 12 study sites in 7 countries; 13 patients were alive, and 35 were dead (including 1 stillborn). Chest deformity, respiratory distress, respiratory failure (as conditioned by the eligibility criteria), failure to thrive, and elevated calcium levels were present in >70% of patients between birth and age 5 years. Vitamin B6-dependent seizures and respiratory distress and failure were associated significantly (P < .05) with the risk of early death. Serum alkaline phosphatase activity in all 41 patients tested (mean [SD]: 18.1 [15.4] U/L) was below the mean lower limit of normal of the reference ranges of the various laboratories (88.2 U/L). Among the 45 patients with relevant data, 29 had received respiratory support, of whom 26 had died at the time of data collection. The likelihood of invasive ventilator-free survival for this cohort decreased to 63% at 3 months, 54% at 6 months, 31% at 12 months, and 25% at 5 years. Patients with perinatal or infantile hypophosphatasia and vitamin B6-dependent seizures, with or without significant respiratory distress or chest deformities, have high morbidity and mortality in the first 5 years of life. ClinicalTrials.gov: NCT01419028.

Identifiants

pubmed: 30979546
pii: S0022-3476(19)30139-8
doi: 10.1016/j.jpeds.2019.01.049
pii:
doi:

Substances chimiques

Alkaline Phosphatase EC 3.1.3.1

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-124.e4

Investigateurs

Michael Beck (M)
Linda DiMeglio (L)
Paul Wuh-Liang Hwu (P)
Peter Simm (P)
Jill Simmons (J)
Joel Steelman (J)
Robert D Steiner (RD)
Andrea Superti-Furga (A)

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Michael P Whyte (MP)

Center for Metabolic Bone Disease and Molecular Research, Shriners Hospital for Children, St Louis, MO; Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine at Barnes-Jewish Hospital, St Louis, MO. Electronic address: mwhyte@shrinenet.org.

Edward Leung (E)

Children's Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada.

William R Wilcox (WR)

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA.

Johannes Liese (J)

University Children's Hospital, University of Würzburg, Würzburg, Germany.

Jesús Argente (J)

Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, CIBERobn, ISCIII, IMDEA Food Institute, CEIUAM+CSIC, Madrid, Spain.

Gabriel Á Martos-Moreno (GÁ)

Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, CIBERobn, ISCIII, IMDEA Food Institute, CEIUAM+CSIC, Madrid, Spain.

Amy Reeves (A)

Center for Metabolic Bone Disease and Molecular Research, Shriners Hospital for Children, St Louis, MO.

Kenji P Fujita (KP)

Clinical Research, Alexion Pharmaceuticals, Inc, Boston, MA.

Scott Moseley (S)

Biostatistics, Alexion Pharmaceuticals, Inc, Boston, MA.

Christine Hofmann (C)

University Children's Hospital, University of Würzburg, Würzburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH